Hybrid Modeling

Accelerating and Improving Bioprocess Development with Machine Learning Solutions

Michael Sokolov, Ph.D.; Alessandro Butté, Ph.D.

DataHow

Down Stream Processing

Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines

Songyoung Kim

Samsung Biologics

Microfluidics

How Microfluidic Devices are Benefitting Biopharmaceutical Development and Manufacturing

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Nice Insight API Report

Small Molecule API Discovery and Development Trends

April Stanley, MS MBA

Viral Vectors

A Viral Vector CDMO Vision that Resonates

Drew Brennan; Chris Berger; Elie Hanania, Ph.D.; Dave Ingamells; Rami Barghout, PE

Avid Bioservices

Downstream Processing

Technological Innovations Enhancing Downstream Productivity and Their Critical Process Parameters for Real-Time Control

Giovanni Campolongo

Hamilton

Failing Fast

Maximizing Resources and Potential for Success by Failing Fast

Nazar Elkarim, Ph.D.

Mikart

Clinical and Commercial Manufacturing

Reach the Patient Quicker with GBI’s Manufacturing Solutions

Muctarr Sesay, Ph.D.

GBI

Risk Management in mRNA Manufacture

Managing Risk in Cutting-Edge mRNA Therapeutics

Jessica Madigan; Normand Blais

BIOVECTRA

Biocatalysis

Olon Presents the First Results Announcing to Have Achieved Developing A New Production Process Through Engineering Target Enzyme

Olon

Lipid Nanoparticles

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

Quality by Design

A Concerted QbD Approach to Development and Manufacturing of Nucleic Acid Therapies

Lynda Menard, Ph.D.; Grant Henderson, Ph.D.

Vernal Biosciences

Sustainable Manufacturing

Sustainability in Pharmaceutical Manufacturing: A CDMO’s Contribution

Mark McLaws, Ph.D.

Asymchem

Quality in mRNA Manufacturing

Quality in Equals Quality Out in mRNA Manufacturing

Judith McCorry

Vernal Biosciences

Real-Time Monitoring

Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing

Stacy Shollenberger

MilliporeSigma

Multispecific Antibodies

Optimized Multispecific Antibody Design, Development, and Manufacturing

Sino Biological

Capacity Expansion

Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business

Avid Bioservices, Inc.

R&D

Driving Further Innovation by Integrating a Decentralized R&D Network

Giorgio Bertolini, Ph.D.

Olon

Viral Vector Manufacturing

Approaching Viral Vector Manufacturing With an Emphasis on Quality and Design

Chris Berger; Atef Khezri

Avid Bioservices

Advanced Excipients

How the Developability Classification System and Advanced Excipients Enable the Formulation of Poorly Soluble APIs

Daniel Joseph Price, Ph.D.

MilliporeSigma